HomeSYNACT • STO
add
SynAct Pharma AB
Previous close
kr 15.92
Day range
kr 17.50 - kr 19.12
Year range
kr 6.79 - kr 23.45
Market cap
917.45M SEK
Avg Volume
261.50K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 28.10M | 9.30% |
Net income | -24.68M | 0.89% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | 18.60% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 51.16M | -0.76% |
Total assets | 219.17M | 2.73% |
Total liabilities | 38.04M | -37.71% |
Total equity | 181.14M | — |
Shares outstanding | 49.01M | — |
Price to book | 4.30 | — |
Return on assets | -28.69% | — |
Return on capital | -35.22% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -24.68M | 0.89% |
Cash from operations | -28.83M | -157.63% |
Cash from investing | — | — |
Cash from financing | 19.70M | 12,894.16% |
Net change in cash | -10.05M | 7.32% |
Free cash flow | -24.98M | -99.28% |
About
Founded
Mar 14, 2012
Website
Employees
6
